Graft-versus-host disease
RareAutoimmune
Graft-versus-host disease is treated with 2 medications in our database, including Imbruvica, Rezurock. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Pharmacyclics, Sanofi. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Graft-versus-host disease treatment below.
What help exists for Graft-versus-host disease
6
drugs indexed
5
with copay cards
5
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Graft-versus-host disease
6 totalJAKAFI
ruxolitinib
🎟💙Rezurock
belumosudil · Sanofi
🎟💙Imbruvica
Ibrutinib · Pharmacyclics
🎟💙Posaconazole
POSACONAZOLE · Merck
🎟💙NOXAFIL
posaconazole · Merck
NIKTIMVO
axatilimab-csfr
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Graft-versus-host disease drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Grants for Graft-versus-host disease patients
3 total · 0 openGraft-versus-host disease is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →